Vesper Medical Announces $37 Million Financing with Vensana Capital and Gilde Healthcare to Complete Development of Its Duo Venous Stent System - BioSpace

Vesper Medical Announces $37 Million Financing with Vensana Capital and Gilde Healthcare to Complete Development of Its Duo Venous Stent System  BioSpace

WAYNE, Pa.--(BUSINESS WIRE)-- Vesper Medical, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more